Jon LaPook, M.D. is the award-winning chief medical correspondent for CBS News. Since joining CBS News in 2006, LaPook has delivered more than 1,200 reports on a wide variety of breaking news and ...
Add Yahoo as a preferred source to see more of our stories on Google. There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in ...
LUBBOCK, Texas (KCBD) - Rebecca Sue Talley, a Lubbock woman who battled ALS for seven years, died March 27. She was 69. Talley became a strong supporter of the West Texas ALS Support Group, which came ...
Scientists in Sunnybrook’s Hurvitz Brain Sciences Program recently made history as they non-invasively opened the blood-brain barrier (BBB) to deliver a small dose of immunotherapy directly to the ...
"Working alongside the ALS community on this book has been one of the most meaningful and fulfilling experiences of my career. While many people impacted by ALS have courageously shared their stories ...
There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results